Therapeutic Drug Monitoring of Vancomycin Concentrations for the Management of Bone and Joint Infections : An Urgent Need
Rio-No, Laura (Parc de Salut MAR de Barcelona)
Sorlí, Luisa 
(Universitat Pompeu Fabra. Facultat de Ciències de la Salut i de la Vida)
Arderiu-Formentí, Alba (Parc de Salut MAR de Barcelona)
de Antonio Ferrer, Marta 
(Parc de Salut MAR de Barcelona)
Martorell, Lucas (Universitat Autònoma de Barcelona. Facultat de Medicina)
Subirana, Isaac 
(Institut Hospital del Mar d'Investigacions Mèdiques)
Puig-Verdié, Lluís
(Parc de Salut MAR de Barcelona)
Alier, Albert (Parc de Salut MAR de Barcelona)
Gómez-Junyent, Joan
(Parc de Salut MAR de Barcelona)
Pérez-Prieto, Daniel
(Parc de Salut MAR de Barcelona)
Luque, Sonia
(Parc de Salut MAR de Barcelona)
Universitat Autònoma de Barcelona
| Date: |
2023 |
| Abstract: |
Vancomycin is used for the treatment of bone and joint infections (BJI), but scarce information is available about its pharmacokinetic/pharmacodynamic (PK/PD) characteristics. We aimed to identify the risk factors associated with the non-achievement of an optimal PK/PD target in the first therapeutic drug monitoring (TDM). Methods: A retrospective study was conducted in a tertiary hospital from January 2020 to January 2022. Patients with BJI and TDM of vancomycin on day 2 of treatment were included. Initial vancomycin fixed doses (1 g every 8 h or 12 h) was decided by the responsible doctors. According to TDM results, dosage adjustments were performed. An AUC/MIC < 400 mg × h/L, between 400 and 600 mg × h/L and. |
| Rights: |
Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, la comunicació pública de l'obra i la creació d'obres derivades, fins i tot amb finalitats comercials, sempre i quan es reconegui l'autoria de l'obra original.  |
| Language: |
Anglès |
| Document: |
Article ; recerca ; Versió publicada |
| Subject: |
Bone and joint infections ;
Vancomycin ;
Therapeutic drug monitoring ;
Pharmacokinetics ;
Nephrotoxicity ;
Dosage regimens |
| Published in: |
Tropical medicine and infectious disease, Vol. 8 (february 2023) , ISSN 2414-6366 |
DOI: 10.3390/tropicalmed8020113
PMID: 36828529
The record appears in these collections:
Articles >
Research articlesArticles >
Published articles
Record created 2023-03-09, last modified 2026-04-19